Regulations for submitting abstracts to Cel-Gen 2026

All abstracts must be written in English, and abstracts selected for oral presentation must also be presented in English.

Submission opening and closing date/time:
Opening: June 1st
Closing: June 30, 12:00 a.m. (midnight) Postponed to July 15, 12:00 a.m. (midnight)

Maximum number of abstracts per author: 3 abstracts

Maximum number of authors per abstract:  15 authors

Title length limit: 250 characters (including spaces)

Abstract length limit: Abstracts are limited to 3,000 characters, including punctuation and spaces (excluding title, authors, and affiliations)

Authors may submit abstracts before completing registration/payment. Registration fees will only be required after abstract acceptance.

Evaluation score/rating scale: up to 6 points

Work presentation formats: Poster and Oral Presentation

Categories:

• Cell therapy and extracellular vesicles - basic research
• Cell therapy and extracellular vesicles - pre-clinical research
• Cell therapy and extracellular vesicles - clinical studies
• Tissue engineering
• Gene Therapy - basic research
• Gene Therapy - pre-clinical studies
• Gene Therapy - clinical studies

Questions: contact@abtcelgen.org.br; temalivre3@mezclaeventos.com.br